Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat

J Neurosci Methods. 2014 Jul 30:232:118-24. doi: 10.1016/j.jneumeth.2014.05.017. Epub 2014 May 24.

Abstract

Background: Chronic pelvic pain (CPP) is defined as long-lasting and severe pelvic pain persisting over six months in cyclic or non-cyclic chronic manner. Various pathologic conditions like endometriosis, abdominal infections, intra-peritoneal adhesions or infection, underlie CPP which is often the leading symptom of the associated diseases. Pharmacological approaches addressing CPP are hampered by the absence of a straight-forward, objective, and reliable method for the assessment of CPP in rodents.

Method: In the presented study, the dynamic weight bearing system (DWB) was employed for the first time for the evaluation of pelvic pain in a rat model of LPS-induced peritonitis. Rats were pretreated with the COX-2 inhibitor rofecoxib and PGE2 levels were evaluated in peritoneal lavage.

Results: DWB analysis revealed that rats treated with LPS showed a relief posture by a significantly increased weight distribution to the front when compared to vehicle-treated animals. This effect was prevented by rofecoxib treatment indicating the sensitivity of the model for pelvic pain related to peritonitis. Analysis of the PGE2 levels in the peritoneal fluid indicated a correlation with the relief posture intensity.

Comparison with existing method(s): In contrast to others weight bearing approaches, the use of DWB allows evaluation of spontaneous posture changes as a consequence of pelvic pain.

Conclusion: Taken together, we were able to show, that DWB combined with LPS-induced peritonitis may deliver a new reliable animal model addressing pelvic pain with high construct validity (peritoneal inflammation), and face validity (pain related relief posture).

Keywords: COX-2; Inflammation; PGE2; Pain; Pelvic; Weight bearing.

MeSH terms

  • Abdominal Pain / diagnosis*
  • Abdominal Pain / drug therapy
  • Abdominal Pain / etiology*
  • Analysis of Variance
  • Animals
  • Cyclooxygenase 2 Inhibitors / therapeutic use
  • Dinoprostone / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Female
  • Lactones / therapeutic use
  • Lipopolysaccharides / toxicity
  • Pain Measurement
  • Peritonitis / chemically induced
  • Peritonitis / complications*
  • Peritonitis / metabolism
  • Rats
  • Rats, Wistar
  • Sulfones / therapeutic use
  • Time Factors
  • Weight-Bearing*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Lactones
  • Lipopolysaccharides
  • Sulfones
  • rofecoxib
  • Dinoprostone